If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,643.00    -58.00 (-2.15%)
Bid:
2,632.00
Ask:
2,633.00
Spread: 1.00 (0.038%)
Market Cap: £23.44b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Directorate Change

21 Dec 2017 10:00

RNS Number : 0587A
Experian plc
21 December 2017
 

Experian plc

 

 

Directorate Change

 

 

21 December 2017 - Experian, the global information services company, announces the appointment of a new independent Non-Executive Director to the Board of Experian plc, effective from 1 April 2018.

 

Dr. Ruba Borno, 36, a US national, is a member of the Executive Leadership Team at Cisco, the worldwide technology leader delivering solutions to help securely connect digital business. In her role at Cisco, she helps guide strategy and leads priority initiatives across key partnerships, technology and investment strategies. Ruba is central to informing Cisco's digital and business transformation and that of its customers and partners.

 

Holding a Ph.D. and a Master of Science in Electrical Engineering, and a Bachelor of Science in Computer Engineering, Ruba was an Intel Ph.D. fellow at the National Science Foundation's Engineering Research Center for Wireless Integrated MicroSystems. She sits on the board of The Tech Museum of Innovation in Silicon Valley. Ruba was previously at The Boston Consulting Group (BCG) where she specialised in helping enterprises through complex technology transformations, and was a leader in BCG's Technology, Media & Telecommunications, and People & Organization practice groups.

 

Don Robert, Chairman of Experian, commented:

 

"I am very pleased to welcome Ruba Borno to the Board of Experian. Ruba will bring advanced technologies expertise, and the Board and Experian will also benefit greatly from her focus on supporting businesses in strategically adapting to the threats and opportunities created by technology, as well as pushing disruptive technology to create new opportunities. We will also benefit from her insight and understanding of digitisation and technology transformation across industries."

 

The Company confirms that there are no details to be disclosed under Listing Rule 9.6.13R, paragraphs (1) to (6).

 

Contacts

 

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4215

Gerry Tschopp Media queries

 

Finsbury

Rollo Head +44 (0)20 7251 3801

Jenny Davey

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 16,000 people operating across 37 countries and every day we're investing in new technologies, talented people and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOATBBLTMBTTMAR
Date   Source Headline
24th Feb 20255:37 pmRNSTransaction in Own Shares
21st Feb 20255:36 pmRNSTransaction in Own Shares
20th Feb 20255:46 pmRNSTransaction in Own Shares
19th Feb 20255:17 pmRNSTransaction in Own Shares
18th Feb 20255:45 pmRNSTransaction in Own Shares
12th Feb 20257:00 amRNSDirectorate Change
10th Feb 20254:08 pmRNSDirector/PDMR Shareholding
31st Jan 202511:41 amRNSTotal Voting Rights
24th Jan 202510:25 amRNSOutcome of audit tender process
17th Jan 20255:14 pmRNSFirst interim dividend
16th Jan 20255:14 pmRNSBond Issue
15th Jan 20257:00 amRNSExperian Q3 FY25 trading update
31st Dec 202410:16 amRNSTotal Voting Rights
23rd Dec 20241:39 pmRNSShare repurchase programme
20th Dec 20249:00 amRNSElections for first interim dividend
12th Dec 20249:25 amRNSDirector Declaration
29th Nov 20243:56 pmRNSTotal Voting Rights
13th Nov 20247:00 amRNSHalf-year Report
5th Nov 20241:51 pmRNSTotal Voting Rights - Amendment
31st Oct 202412:19 pmRNSTotal Voting Rights
4th Oct 202412:44 pmRNSExperian to acquire Clearsale in Brazil
30th Sep 202412:30 pmRNSTotal Voting Rights
30th Sep 20248:29 amRNSExperian Completes Acquisition of Ilion
16th Sep 202412:10 pmRNSBlock listing Interim Review
4th Sep 20243:30 pmRNSBond Issue
30th Aug 20243:15 pmRNSTotal Voting Rights
7th Aug 20249:34 amRNSDirector/PDMR Shareholding
31st Jul 202410:59 amRNSTotal Voting Rights
23rd Jul 202410:13 amRNSDirector/PDMR Shareholding
17th Jul 202411:15 amRNSResult of AGM
16th Jul 20247:00 amRNSDirectorate Change
16th Jul 20247:00 amRNSTrading update, first quarter
28th Jun 20245:35 pmRNSSecond interim dividend
28th Jun 20243:10 pmRNSTotal Voting Rights
27th Jun 20249:15 amRNSDirector/PDMR Shareholding
17th Jun 20244:00 pmRNSDirector/PDMR Shareholding
12th Jun 202411:30 amRNSDirector/PDMR Shareholding
7th Jun 20241:34 pmRNSAnnual Financial Report
31st May 20244:12 pmRNSTotal Voting Rights
31st May 20249:36 amRNSElections for Second Interim Dividend
23rd May 20245:30 pmRNSHolding(s) in Company
15th May 20241:30 pmRNSShare repurchases
15th May 20247:00 amRNSFull-year financial report
30th Apr 20245:24 pmRNSTransaction in Own Shares
30th Apr 202411:22 amRNSTotal Voting Rights
29th Apr 20245:52 pmRNSTransaction in Own Shares
26th Apr 20245:19 pmRNSTransaction in Own Shares
25th Apr 20245:16 pmRNSTransaction in Own Shares
24th Apr 20245:14 pmRNSTransaction in Own Shares
23rd Apr 20245:28 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.